Treatment of carbapenem-resistant Pseudomonas aeruginosa infections: a case for cefiderocol

R Canton, Y Doi, PJ Simner - Expert Review of Anti-infective …, 2022 - Taylor & Francis
ABSTRACT Introduction Carbapenem-resistant (CR) Pseudomonas aeruginosa infections
constitute a serious clinical threat globally. Patients are often critically ill and/or …